Harvard alumnus James E. Rothman shares Nobel Prize in medicine

Yale cell biologist, two others, are recognized for work on vesicles and cellular transport.

James E. Rothman, Ph. D. '76—now Wallace professor of biomedical sciences at Yale, chair of the medical school's department of cell biology, and founding director of Yale's nanobiology institute—has been awarded the 2013 Nobel Prize in Physiology or Medicine with Randy W. Schekman, of the University of California, Berkeley, and Thomas C. Südhof, of Stanford. The three scientists were recognized for "their discoveries of machinery regulating vesicle traffic, a major transport system in our cells."

According to Rothman's biography, he earned his Ph.D. degree in biological chemistry and was a student at Harvard Medical School from 1971 to 1973. From 1976 to 1978, he was a fellow in MIT's department of biology. From 1978 to 1988, he was a professor in the department of biochemistry at Stanford. He was Squibb professor of molecular biology at Princeton from 1988 to 1991 and then founded and chaired the department of cellular biochemistry and biophysics at Memorial Sloan-Kettering Cancer Center (1991-2004), where he served as vice-chairman of Sloan-Kettering. Before moving to Yale in 2008, Rothman was Wu professor of chemical biology and director of Columbia University’s Sulzberger Genome Center.

His biography cites discovery of 

key molecular machinery responsible for transfer of materials among compartments within cells, providing the conceptual framework for understanding such diverse and important processes as the release of insulin into the blood, communication between nerve cells in the brain, and the entry of viruses to infect cells. Numerous kinds of tiny membrane-enveloped vesicles ferry packets of enclosed cargo. Each type of vesicle must deliver its specialized cargo to the correct destination among the maze of distinct compartments that populate the cytoplasm of a complex animal cell. The delivery process, termed membrane fusion, is fundamental for physiology and medicine, as pathology in this process can cause metabolic, neuropsychiatric and other diseases. Rothman reconstituted vesicle budding and fusion in a cell-free system (1984) and discovered the complex of SNARE proteins (1993) which mediates membrane fusion and affords it specificity. He also uncovered the GTPase-switch mechanism which controls coated vesicle budding in the cell (1991).

Related topics

You might also like

Eating for the Holidays, the Planet, and Your Heart

“Sustainable eating,” and healthy recipes you can prepare for the holidays.

Five Questions with Michèle Duguay

A Harvard scholar of music theory on how streaming services have changed the experience of music

Harvard Faculty Discuss Tenure Denials

New data show a shift in when, in the process, rejections occur

Most popular

U.S. Appeals Court Preserves NIH Research Funding

The court made permanent an injunction preventing caps on reimbursement for overhead costs.

Sign of the Times: Harvard Quarterback Jaden Craig Will Play for TCU

Out of eligibility for the Crimson, the star entered the transfer portal.  

Seth Moulton, Harvard graduate and former Marine, is profiled

A profile of former Marine Seth Moulton ’01, M.B.A.-M.P.P. ’11

Explore More From Current Issue

A jubilant graduate shouts into a megaphone, surrounded by a cheering crowd.

For Campus Speech, Civility is a Cultural Practice

A former Harvard College dean reviews Princeton President Christopher Eisgruber’s book Terms of Respect.

A girl sits at a desk, flanked by colorful, stylized figures, evoking a whimsical, surreal atmosphere.

The Trouble with Sidechat

No one feels responsible for what happens on Harvard’s anonymous social media app.

Historic church steeple framed by bare tree branches against a clear sky.

Harvard’s Financial Challenges Lead to Difficult Choices

The University faces the consequences of the Trump administration—and its own bureaucracy